Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 69 | 2023 | 1020 | 6.080 |
Why?
|
Erythrocytes | 106 | 2023 | 2455 | 5.350 |
Why?
|
Reticulocytes | 29 | 2022 | 290 | 3.600 |
Why?
|
Symporters | 30 | 2022 | 362 | 2.900 |
Why?
|
Potassium | 61 | 2022 | 1336 | 2.590 |
Why?
|
Anemia, Iron-Deficiency | 16 | 2021 | 364 | 2.520 |
Why?
|
Erythrocytes, Abnormal | 18 | 2018 | 125 | 2.050 |
Why?
|
Hemoglobins | 34 | 2021 | 1531 | 2.030 |
Why?
|
Erythrocyte Membrane | 32 | 2015 | 442 | 2.030 |
Why?
|
beta-Thalassemia | 13 | 2023 | 225 | 2.020 |
Why?
|
Intermediate-Conductance Calcium-Activated Potassium Channels | 13 | 2022 | 44 | 1.490 |
Why?
|
Clotrimazole | 22 | 2008 | 77 | 1.460 |
Why?
|
Editorial Policies | 16 | 2016 | 451 | 1.440 |
Why?
|
Erythropoiesis | 18 | 2018 | 706 | 1.440 |
Why?
|
Chlorides | 30 | 2022 | 667 | 1.400 |
Why?
|
Blood Cell Count | 6 | 2021 | 403 | 1.190 |
Why?
|
Erythrocyte Indices | 18 | 2019 | 146 | 1.160 |
Why?
|
Hemoglobin, Sickle | 17 | 2022 | 122 | 1.120 |
Why?
|
Anemia, Hemolytic, Congenital | 9 | 2019 | 69 | 1.110 |
Why?
|
Hydrops Fetalis | 9 | 2019 | 107 | 1.090 |
Why?
|
Hematologic Diseases | 4 | 2021 | 498 | 1.080 |
Why?
|
Erythropoietin | 21 | 2006 | 726 | 1.080 |
Why?
|
Magnesium | 14 | 2011 | 813 | 1.070 |
Why?
|
Ion Transport | 18 | 2017 | 320 | 1.060 |
Why?
|
Reticulocyte Count | 14 | 2021 | 37 | 1.050 |
Why?
|
Iron | 21 | 2023 | 1774 | 1.020 |
Why?
|
Glycine Plasma Membrane Transport Proteins | 2 | 2021 | 21 | 0.980 |
Why?
|
Hydroxyurea | 14 | 2021 | 289 | 0.950 |
Why?
|
Potassium Channels, Calcium-Activated | 7 | 2005 | 49 | 0.900 |
Why?
|
Cations | 13 | 2022 | 232 | 0.900 |
Why?
|
Hematology | 3 | 2016 | 221 | 0.860 |
Why?
|
Spherocytosis, Hereditary | 8 | 2023 | 80 | 0.810 |
Why?
|
Hemolysis | 13 | 2021 | 420 | 0.810 |
Why?
|
Journalism, Medical | 4 | 2016 | 73 | 0.800 |
Why?
|
Antisickling Agents | 9 | 2014 | 80 | 0.800 |
Why?
|
Sulfones | 2 | 2021 | 434 | 0.790 |
Why?
|
Iron Compounds | 1 | 2021 | 20 | 0.790 |
Why?
|
Trityl Compounds | 5 | 2021 | 12 | 0.780 |
Why?
|
Potassium Channels | 17 | 1999 | 563 | 0.770 |
Why?
|
Sodium | 29 | 2013 | 1622 | 0.770 |
Why?
|
Potassium Channel Blockers | 8 | 2017 | 171 | 0.730 |
Why?
|
Adenoidectomy | 2 | 2020 | 159 | 0.730 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 11 | 2011 | 153 | 0.690 |
Why?
|
Acetamides | 5 | 2021 | 248 | 0.670 |
Why?
|
Tonsillectomy | 2 | 2020 | 255 | 0.650 |
Why?
|
Periodicals as Topic | 8 | 2016 | 1429 | 0.640 |
Why?
|
Erythrocyte Count | 11 | 2021 | 163 | 0.640 |
Why?
|
Specimen Handling | 10 | 2014 | 694 | 0.630 |
Why?
|
Postoperative Hemorrhage | 2 | 2020 | 409 | 0.620 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 367 | 0.600 |
Why?
|
Calcium | 25 | 2010 | 5755 | 0.600 |
Why?
|
Anemia, Hypochromic | 3 | 2015 | 66 | 0.580 |
Why?
|
Piperazines | 4 | 2023 | 2487 | 0.580 |
Why?
|
Carrier Proteins | 22 | 2019 | 5021 | 0.570 |
Why?
|
Ion Channels | 12 | 2019 | 1056 | 0.540 |
Why?
|
Anemia, Hemolytic | 4 | 2023 | 168 | 0.540 |
Why?
|
Disclosure | 9 | 2012 | 737 | 0.510 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2015 | 91 | 0.510 |
Why?
|
Blood Proteins | 5 | 2012 | 1125 | 0.490 |
Why?
|
Fetal Hemoglobin | 14 | 2023 | 341 | 0.490 |
Why?
|
Biological Transport | 33 | 2015 | 2119 | 0.480 |
Why?
|
Pyrrolidonecarboxylic Acid | 4 | 2007 | 65 | 0.480 |
Why?
|
Blood Chemical Analysis | 2 | 2014 | 440 | 0.470 |
Why?
|
Dehydration | 10 | 2019 | 232 | 0.470 |
Why?
|
Water-Electrolyte Balance | 9 | 2001 | 346 | 0.460 |
Why?
|
von Willebrand Diseases | 1 | 2015 | 127 | 0.450 |
Why?
|
Point-of-Care Systems | 2 | 2021 | 1177 | 0.450 |
Why?
|
Quantitative Trait Loci | 6 | 2017 | 2018 | 0.430 |
Why?
|
Phosphoprotein Phosphatases | 5 | 2005 | 338 | 0.430 |
Why?
|
Hemoglobin SC Disease | 5 | 2022 | 22 | 0.420 |
Why?
|
Anemia | 10 | 2019 | 1502 | 0.420 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 5 | 2010 | 60 | 0.410 |
Why?
|
Antiporters | 5 | 2004 | 277 | 0.390 |
Why?
|
von Willebrand Factor | 1 | 2015 | 669 | 0.380 |
Why?
|
Humans | 217 | 2023 | 743811 | 0.380 |
Why?
|
Ferritins | 10 | 2021 | 590 | 0.380 |
Why?
|
Clinical Medicine | 4 | 2012 | 147 | 0.370 |
Why?
|
Mice | 75 | 2023 | 81154 | 0.370 |
Why?
|
Clinical Laboratory Techniques | 6 | 2012 | 738 | 0.360 |
Why?
|
beta-Globins | 1 | 2010 | 115 | 0.360 |
Why?
|
Chromosomes, Mammalian | 1 | 2010 | 151 | 0.360 |
Why?
|
Animals | 103 | 2023 | 168660 | 0.350 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 13 | 2013 | 494 | 0.350 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2008 | 9 | 0.340 |
Why?
|
Reference Values | 15 | 2021 | 4974 | 0.320 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2210 | 0.310 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2008 | 33 | 0.310 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2000 | 281 | 0.310 |
Why?
|
Mutation, Missense | 6 | 2019 | 2566 | 0.300 |
Why?
|
Hydrogen-Ion Concentration | 15 | 2022 | 2556 | 0.300 |
Why?
|
Erythroblasts | 4 | 2014 | 150 | 0.300 |
Why?
|
Forkhead Transcription Factors | 4 | 2021 | 1613 | 0.300 |
Why?
|
Hyperkalemia | 3 | 2016 | 218 | 0.300 |
Why?
|
Spherocytes | 2 | 2012 | 9 | 0.290 |
Why?
|
Erythrocyte Volume | 6 | 2007 | 30 | 0.290 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 211 | 0.290 |
Why?
|
Ethylmaleimide | 5 | 2001 | 76 | 0.290 |
Why?
|
Genomics | 2 | 2021 | 5714 | 0.280 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2008 | 362 | 0.280 |
Why?
|
Nitroso Compounds | 1 | 2006 | 72 | 0.280 |
Why?
|
Multiple Myeloma | 2 | 2023 | 5185 | 0.280 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2006 | 66 | 0.270 |
Why?
|
Osmotic Fragility | 8 | 2019 | 37 | 0.260 |
Why?
|
Serum Albumin, Bovine | 1 | 2006 | 324 | 0.260 |
Why?
|
Hematinics | 1 | 2008 | 280 | 0.260 |
Why?
|
Scorpion Venoms | 2 | 1995 | 31 | 0.250 |
Why?
|
Dietary Supplements | 5 | 2017 | 3292 | 0.250 |
Why?
|
Disease Models, Animal | 25 | 2023 | 18027 | 0.240 |
Why?
|
Mice, Transgenic | 18 | 2021 | 9731 | 0.240 |
Why?
|
Plasmodium knowlesi | 2 | 2015 | 22 | 0.240 |
Why?
|
Administration, Oral | 11 | 2021 | 3912 | 0.240 |
Why?
|
Osmolar Concentration | 8 | 2006 | 683 | 0.240 |
Why?
|
Haplotypes | 2 | 2010 | 2779 | 0.240 |
Why?
|
Cell Size | 8 | 2019 | 641 | 0.240 |
Why?
|
Metabolic Networks and Pathways | 1 | 2008 | 783 | 0.240 |
Why?
|
Iron Overload | 2 | 2023 | 242 | 0.240 |
Why?
|
Genetic Variation | 6 | 2017 | 6535 | 0.230 |
Why?
|
Hematocrit | 14 | 2012 | 636 | 0.230 |
Why?
|
Membrane Proteins | 10 | 2014 | 7880 | 0.230 |
Why?
|
Doping in Sports | 2 | 2000 | 63 | 0.230 |
Why?
|
Transferrin | 4 | 2021 | 295 | 0.230 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3608 | 0.230 |
Why?
|
alpha-Thalassemia | 2 | 2014 | 46 | 0.220 |
Why?
|
Antifungal Agents | 6 | 1997 | 729 | 0.220 |
Why?
|
Pyruvate Kinase | 2 | 2023 | 189 | 0.220 |
Why?
|
Potassium Chloride | 2 | 2003 | 237 | 0.220 |
Why?
|
Hemoglobin C Disease | 3 | 1989 | 8 | 0.220 |
Why?
|
Conflict of Interest | 4 | 2011 | 544 | 0.220 |
Why?
|
Administrative Personnel | 2 | 1994 | 187 | 0.220 |
Why?
|
Receptors, Erythropoietin | 2 | 2022 | 147 | 0.220 |
Why?
|
Recombinant Proteins | 18 | 2004 | 6620 | 0.210 |
Why?
|
Oxidative Stress | 5 | 2007 | 3082 | 0.210 |
Why?
|
Vasodilator Agents | 2 | 2006 | 974 | 0.210 |
Why?
|
Sodium-Potassium-Chloride Symporters | 7 | 2006 | 102 | 0.210 |
Why?
|
Bumetanide | 8 | 2006 | 95 | 0.210 |
Why?
|
Hydrocephalus | 2 | 2000 | 748 | 0.210 |
Why?
|
Ouabain | 10 | 2011 | 264 | 0.210 |
Why?
|
Male | 82 | 2021 | 349776 | 0.210 |
Why?
|
Erythrocyte Aging | 5 | 2012 | 52 | 0.210 |
Why?
|
Calpain | 2 | 2012 | 150 | 0.210 |
Why?
|
Athletes | 2 | 2021 | 1093 | 0.210 |
Why?
|
Cell Count | 5 | 2017 | 1855 | 0.210 |
Why?
|
Erythrocyte Deformability | 5 | 2017 | 56 | 0.200 |
Why?
|
Nitric Oxide | 4 | 2006 | 2132 | 0.200 |
Why?
|
Calcium Channel Blockers | 3 | 2002 | 692 | 0.200 |
Why?
|
Infusions, Intravenous | 3 | 2021 | 2274 | 0.200 |
Why?
|
DNA Virus Infections | 1 | 2021 | 14 | 0.200 |
Why?
|
Hemoglobin A | 3 | 1999 | 87 | 0.200 |
Why?
|
Imidazoles | 4 | 1996 | 1206 | 0.200 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1995 | 1574 | 0.200 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2001 | 15 | 0.200 |
Why?
|
Enzyme Activators | 1 | 2021 | 57 | 0.200 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2016 | 560 | 0.190 |
Why?
|
Rheology | 2 | 2019 | 345 | 0.190 |
Why?
|
Female | 78 | 2021 | 380020 | 0.190 |
Why?
|
Thalassemia | 3 | 1999 | 273 | 0.190 |
Why?
|
Pathology | 2 | 1994 | 272 | 0.190 |
Why?
|
Blood Donors | 2 | 1993 | 355 | 0.190 |
Why?
|
Ion Channel Gating | 4 | 1999 | 437 | 0.190 |
Why?
|
Flow Cytometry | 7 | 2021 | 5973 | 0.190 |
Why?
|
TRPV Cation Channels | 1 | 2021 | 237 | 0.180 |
Why?
|
Kinetics | 10 | 2005 | 6476 | 0.180 |
Why?
|
Plasmodium falciparum | 3 | 2015 | 1730 | 0.180 |
Why?
|
Okadaic Acid | 4 | 2006 | 67 | 0.180 |
Why?
|
Blood Coagulation Tests | 2 | 2019 | 263 | 0.180 |
Why?
|
Patch-Clamp Techniques | 7 | 2017 | 964 | 0.170 |
Why?
|
Endothelins | 1 | 1999 | 138 | 0.170 |
Why?
|
Mutation | 15 | 2021 | 29777 | 0.170 |
Why?
|
Research Support as Topic | 4 | 2011 | 705 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 6 | 2019 | 3389 | 0.170 |
Why?
|
Integrases | 1 | 2022 | 533 | 0.170 |
Why?
|
Mice, Inbred C57BL | 23 | 2019 | 21824 | 0.170 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1027 | 0.170 |
Why?
|
Cerebrospinal Fluid | 2 | 2017 | 533 | 0.170 |
Why?
|
Mice, Knockout | 16 | 2021 | 14563 | 0.170 |
Why?
|
Plasmodium vivax | 1 | 2021 | 208 | 0.170 |
Why?
|
Oxygen | 7 | 2015 | 4189 | 0.170 |
Why?
|
Malaria, Vivax | 1 | 2021 | 173 | 0.170 |
Why?
|
Iron Chelating Agents | 2 | 1999 | 139 | 0.160 |
Why?
|
Leukocyte Count | 5 | 2019 | 1588 | 0.160 |
Why?
|
Immune System Diseases | 1 | 2021 | 261 | 0.160 |
Why?
|
Industry | 5 | 2011 | 366 | 0.160 |
Why?
|
Blood Viscosity | 1 | 2018 | 124 | 0.160 |
Why?
|
Hypertonic Solutions | 3 | 2006 | 93 | 0.160 |
Why?
|
Enzyme Inhibitors | 7 | 2013 | 3794 | 0.160 |
Why?
|
Quantitative Trait, Heritable | 3 | 2019 | 544 | 0.160 |
Why?
|
Biomedical Research | 8 | 2012 | 3308 | 0.160 |
Why?
|
Host-Parasite Interactions | 3 | 2015 | 294 | 0.160 |
Why?
|
Injections, Intravenous | 4 | 2012 | 1422 | 0.160 |
Why?
|
Ionophores | 4 | 2011 | 107 | 0.160 |
Why?
|
Kidney Failure, Chronic | 3 | 2006 | 2534 | 0.160 |
Why?
|
Cell Membrane Permeability | 8 | 2001 | 589 | 0.160 |
Why?
|
Acoustics | 1 | 2019 | 239 | 0.150 |
Why?
|
Furosemide | 7 | 1988 | 167 | 0.150 |
Why?
|
Glutamine | 1 | 2020 | 579 | 0.150 |
Why?
|
Mice, Inbred DBA | 5 | 2010 | 642 | 0.150 |
Why?
|
Membrane Potentials | 6 | 2019 | 1137 | 0.150 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 372 | 0.150 |
Why?
|
Crosses, Genetic | 4 | 2010 | 791 | 0.150 |
Why?
|
Globins | 4 | 1997 | 416 | 0.150 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1534 | 0.150 |
Why?
|
Rabbits | 10 | 2012 | 4894 | 0.150 |
Why?
|
Diagnostic Tests, Routine | 2 | 2014 | 782 | 0.150 |
Why?
|
Iron, Dietary | 1 | 2017 | 141 | 0.150 |
Why?
|
Peptides | 4 | 2010 | 4406 | 0.140 |
Why?
|
Phenylhydrazines | 2 | 1994 | 28 | 0.140 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 841 | 0.140 |
Why?
|
src-Family Kinases | 4 | 2008 | 551 | 0.140 |
Why?
|
Brain Damage, Chronic | 1 | 1997 | 263 | 0.140 |
Why?
|
Antioxidants | 1 | 2004 | 1658 | 0.140 |
Why?
|
Cell Fractionation | 1 | 2016 | 251 | 0.140 |
Why?
|
Drug Industry | 3 | 2010 | 746 | 0.140 |
Why?
|
Nutritional Requirements | 1 | 2017 | 286 | 0.140 |
Why?
|
Trophozoites | 1 | 2015 | 12 | 0.140 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7270 | 0.140 |
Why?
|
Child, Preschool | 14 | 2021 | 40964 | 0.140 |
Why?
|
Quinolines | 1 | 2021 | 732 | 0.140 |
Why?
|
Adult | 45 | 2021 | 213889 | 0.140 |
Why?
|
Plasmodium yoelii | 1 | 2015 | 39 | 0.130 |
Why?
|
Hematologic Tests | 4 | 2005 | 240 | 0.130 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2017 | 186 | 0.130 |
Why?
|
Itraconazole | 1 | 1995 | 43 | 0.130 |
Why?
|
Calcium Channels | 2 | 2010 | 622 | 0.130 |
Why?
|
2,3-Diphosphoglycerate | 1 | 2014 | 15 | 0.130 |
Why?
|
Receptors, Drug | 1 | 1995 | 161 | 0.130 |
Why?
|
Blood Coagulation | 2 | 2019 | 1127 | 0.130 |
Why?
|
Species Specificity | 4 | 2013 | 2480 | 0.130 |
Why?
|
Rubidium | 5 | 2011 | 133 | 0.130 |
Why?
|
Receptor, TIE-2 | 1 | 2015 | 177 | 0.130 |
Why?
|
Pyridones | 2 | 1999 | 711 | 0.130 |
Why?
|
Diarrhea | 2 | 2021 | 1348 | 0.120 |
Why?
|
Isotonic Solutions | 2 | 2006 | 119 | 0.120 |
Why?
|
Fibrinogen | 2 | 1998 | 894 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2021 | 19894 | 0.120 |
Why?
|
Body Water | 4 | 2001 | 343 | 0.120 |
Why?
|
Malaria, Falciparum | 2 | 2015 | 1075 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5319 | 0.120 |
Why?
|
Kidney Diseases | 4 | 2018 | 2146 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2002 | 1222 | 0.120 |
Why?
|
Hypophosphatemia | 1 | 2014 | 86 | 0.120 |
Why?
|
Sulfhydryl Compounds | 1 | 1995 | 298 | 0.120 |
Why?
|
Signal Transduction | 5 | 2015 | 23398 | 0.120 |
Why?
|
Child | 20 | 2021 | 77637 | 0.120 |
Why?
|
Glucuronosyltransferase | 1 | 2014 | 128 | 0.120 |
Why?
|
Phylogeny | 1 | 2021 | 2796 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2018 | 1524 | 0.120 |
Why?
|
Mutagenesis | 2 | 2017 | 1263 | 0.120 |
Why?
|
Blood Preservation | 1 | 2014 | 177 | 0.120 |
Why?
|
Electrolytes | 2 | 1985 | 282 | 0.120 |
Why?
|
Adolescent | 20 | 2021 | 85729 | 0.110 |
Why?
|
Immunoassay | 1 | 1997 | 751 | 0.110 |
Why?
|
Lithium | 6 | 1993 | 601 | 0.110 |
Why?
|
Endothelin-1 | 3 | 2015 | 314 | 0.110 |
Why?
|
Protein Kinase C | 3 | 2004 | 1227 | 0.110 |
Why?
|
Equipment Design | 1 | 2021 | 3574 | 0.110 |
Why?
|
Sirtuin 1 | 1 | 2014 | 246 | 0.110 |
Why?
|
History, 21st Century | 2 | 2016 | 1532 | 0.110 |
Why?
|
Priapism | 1 | 2012 | 31 | 0.110 |
Why?
|
Stilbenes | 1 | 2013 | 157 | 0.110 |
Why?
|
Renal Replacement Therapy | 1 | 2014 | 258 | 0.110 |
Why?
|
Chronic Disease | 3 | 2008 | 9139 | 0.110 |
Why?
|
Immersion | 1 | 1992 | 34 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2865 | 0.100 |
Why?
|
Mice, Mutant Strains | 4 | 2012 | 1862 | 0.100 |
Why?
|
Automation | 1 | 2014 | 584 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2018 | 877 | 0.100 |
Why?
|
Alleles | 4 | 2018 | 6934 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2703 | 0.100 |
Why?
|
Zoonoses | 1 | 2013 | 183 | 0.100 |
Why?
|
Stem Cells | 2 | 2015 | 3566 | 0.100 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2012 | 326 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12954 | 0.100 |
Why?
|
Hemochromatosis | 2 | 2008 | 184 | 0.100 |
Why?
|
Calcimycin | 4 | 2022 | 222 | 0.100 |
Why?
|
Infant, Premature, Diseases | 1 | 1997 | 703 | 0.100 |
Why?
|
Chemistry, Clinical | 3 | 2011 | 63 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3591 | 0.100 |
Why?
|
Skin Ulcer | 1 | 2012 | 120 | 0.100 |
Why?
|
Bone Marrow | 2 | 2021 | 2951 | 0.100 |
Why?
|
Cytokines | 3 | 2018 | 7324 | 0.100 |
Why?
|
Erythroid Precursor Cells | 5 | 2019 | 218 | 0.100 |
Why?
|
Mice, Inbred C3H | 2 | 2010 | 964 | 0.100 |
Why?
|
Receptors, Endothelin | 2 | 2002 | 58 | 0.100 |
Why?
|
Receptor, Endothelin B | 2 | 2002 | 41 | 0.100 |
Why?
|
Reagent Kits, Diagnostic | 4 | 2012 | 224 | 0.090 |
Why?
|
Mice, Inbred A | 1 | 2010 | 248 | 0.090 |
Why?
|
History, 20th Century | 2 | 2016 | 2736 | 0.090 |
Why?
|
Heme | 1 | 2012 | 306 | 0.090 |
Why?
|
Genetic Testing | 2 | 2021 | 3439 | 0.090 |
Why?
|
Hydrogen | 2 | 2006 | 164 | 0.090 |
Why?
|
Infant | 11 | 2021 | 35122 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 56392 | 0.090 |
Why?
|
Pathology, Clinical | 2 | 2006 | 368 | 0.090 |
Why?
|
Family | 2 | 2019 | 3144 | 0.090 |
Why?
|
Dipyridamole | 2 | 2010 | 145 | 0.090 |
Why?
|
Metabolism, Inborn Errors | 1 | 2012 | 288 | 0.090 |
Why?
|
Microwaves | 1 | 1992 | 191 | 0.090 |
Why?
|
Spider Venoms | 1 | 2010 | 44 | 0.090 |
Why?
|
Laboratories | 2 | 2011 | 462 | 0.090 |
Why?
|
Chemokine CCL5 | 2 | 2002 | 209 | 0.090 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14714 | 0.090 |
Why?
|
Automation, Laboratory | 1 | 2010 | 101 | 0.090 |
Why?
|
Milk Proteins | 2 | 2001 | 167 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2015 | 454 | 0.090 |
Why?
|
Electric Conductivity | 3 | 2008 | 410 | 0.090 |
Why?
|
Polymorphism, Genetic | 3 | 2015 | 4326 | 0.090 |
Why?
|
Rubidium Radioisotopes | 3 | 2009 | 85 | 0.090 |
Why?
|
Base Sequence | 12 | 2019 | 12798 | 0.090 |
Why?
|
Nystatin | 3 | 2011 | 23 | 0.090 |
Why?
|
Biological Transport, Active | 4 | 1998 | 349 | 0.090 |
Why?
|
Blood Vessels | 1 | 2015 | 1124 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2044 | 0.080 |
Why?
|
Financing, Organized | 1 | 2010 | 202 | 0.080 |
Why?
|
Reference Standards | 3 | 2021 | 1023 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 2005 | 1826 | 0.080 |
Why?
|
Oxidation-Reduction | 4 | 2012 | 2183 | 0.080 |
Why?
|
Microfilament Proteins | 2 | 2006 | 1152 | 0.080 |
Why?
|
Research Report | 1 | 2012 | 355 | 0.080 |
Why?
|
Antimalarials | 1 | 2015 | 904 | 0.080 |
Why?
|
Erythrocyte Aggregation | 2 | 2006 | 36 | 0.080 |
Why?
|
Valinomycin | 1 | 2008 | 19 | 0.080 |
Why?
|
Cell Separation | 1 | 2014 | 1750 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2281 | 0.080 |
Why?
|
Academies and Institutes | 1 | 2011 | 317 | 0.080 |
Why?
|
Plasma | 1 | 1992 | 575 | 0.080 |
Why?
|
Papio | 2 | 2007 | 656 | 0.080 |
Why?
|
Renal Dialysis | 3 | 2004 | 1783 | 0.080 |
Why?
|
Acidosis, Renal Tubular | 2 | 1998 | 51 | 0.080 |
Why?
|
Rolipram | 1 | 2008 | 27 | 0.080 |
Why?
|
Water | 4 | 2015 | 1394 | 0.080 |
Why?
|
Vascular Diseases | 2 | 2015 | 1161 | 0.080 |
Why?
|
Pain | 2 | 2020 | 4987 | 0.080 |
Why?
|
Cytoskeletal Proteins | 3 | 2005 | 1364 | 0.080 |
Why?
|
Homeostasis | 3 | 2018 | 3337 | 0.080 |
Why?
|
Arginine | 2 | 2006 | 943 | 0.080 |
Why?
|
Sirolimus | 1 | 2015 | 1565 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1366 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3874 | 0.080 |
Why?
|
Internship and Residency | 3 | 2006 | 5787 | 0.080 |
Why?
|
Curriculum | 2 | 2006 | 3603 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 2988 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 7908 | 0.070 |
Why?
|
Immunotherapy | 1 | 2023 | 4437 | 0.070 |
Why?
|
Substance-Related Disorders | 2 | 2000 | 4254 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2021 | 63042 | 0.070 |
Why?
|
Cell Hypoxia | 1 | 2010 | 675 | 0.070 |
Why?
|
Dialysis | 1 | 2006 | 74 | 0.070 |
Why?
|
Charybdotoxin | 3 | 1997 | 24 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2011 | 25609 | 0.070 |
Why?
|
Sulfates | 4 | 2011 | 390 | 0.070 |
Why?
|
Membrane Transport Modulators | 1 | 2006 | 24 | 0.070 |
Why?
|
Cells, Cultured | 9 | 2022 | 19232 | 0.070 |
Why?
|
Endothelium, Vascular | 5 | 2015 | 4459 | 0.070 |
Why?
|
Pneumonia | 1 | 2018 | 2133 | 0.070 |
Why?
|
Carbon Monoxide | 1 | 2010 | 531 | 0.070 |
Why?
|
Growth Inhibitors | 2 | 1999 | 385 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3338 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 993 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 805 | 0.070 |
Why?
|
Structure-Activity Relationship | 4 | 2016 | 3128 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2010 | 6380 | 0.070 |
Why?
|
ROC Curve | 3 | 2014 | 3527 | 0.070 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1311 | 0.070 |
Why?
|
Cross-Linking Reagents | 1 | 2009 | 694 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 1997 | 2647 | 0.070 |
Why?
|
Drug Evaluation | 2 | 2006 | 647 | 0.070 |
Why?
|
Plasma Membrane Calcium-Transporting ATPases | 2 | 2017 | 16 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2015 | 1344 | 0.070 |
Why?
|
Heterozygote | 4 | 2017 | 2803 | 0.070 |
Why?
|
Furaldehyde | 1 | 2005 | 3 | 0.070 |
Why?
|
Fas Ligand Protein | 1 | 2006 | 216 | 0.070 |
Why?
|
Peroxynitrous Acid | 1 | 2005 | 41 | 0.070 |
Why?
|
Chromosome Mapping | 2 | 2007 | 4737 | 0.060 |
Why?
|
Temperature | 1 | 1992 | 2202 | 0.060 |
Why?
|
Hydroxyethylrutoside | 1 | 2004 | 4 | 0.060 |
Why?
|
Anemia, Sideroblastic | 2 | 2012 | 101 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1789 | 0.060 |
Why?
|
Protein Phosphatase 1 | 1 | 2005 | 137 | 0.060 |
Why?
|
Cell Adhesion | 3 | 2011 | 3144 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2008 | 13691 | 0.060 |
Why?
|
Centrifugation, Density Gradient | 2 | 1999 | 313 | 0.060 |
Why?
|
Annexins | 1 | 2004 | 38 | 0.060 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12259 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2110 | 0.060 |
Why?
|
Spectrin | 3 | 2002 | 177 | 0.060 |
Why?
|
Adolescent Medicine | 1 | 2005 | 72 | 0.060 |
Why?
|
Platelet Count | 2 | 2005 | 780 | 0.060 |
Why?
|
Gene Targeting | 4 | 2004 | 879 | 0.060 |
Why?
|
Receptors, Transferrin | 2 | 2003 | 296 | 0.060 |
Why?
|
Molecular Sequence Data | 10 | 2013 | 18107 | 0.060 |
Why?
|
Lipoproteins, HDL | 2 | 2002 | 640 | 0.060 |
Why?
|
Publishing | 1 | 2012 | 833 | 0.060 |
Why?
|
Codon | 3 | 2016 | 611 | 0.060 |
Why?
|
Amino Acid Substitution | 3 | 2016 | 1793 | 0.060 |
Why?
|
Phosphorylation | 4 | 2005 | 8436 | 0.060 |
Why?
|
Renin | 2 | 1983 | 642 | 0.060 |
Why?
|
Time Factors | 10 | 2019 | 40038 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2200 | 0.060 |
Why?
|
Forecasting | 1 | 2012 | 2950 | 0.060 |
Why?
|
Pedigree | 4 | 2014 | 4643 | 0.060 |
Why?
|
Blood Cells | 1 | 2005 | 310 | 0.060 |
Why?
|
Xenopus laevis | 3 | 2013 | 956 | 0.050 |
Why?
|
Chromosomes | 1 | 2006 | 596 | 0.050 |
Why?
|
Platelet Aggregation | 1 | 2006 | 798 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 637 | 0.050 |
Why?
|
Acetic Acid | 1 | 2022 | 55 | 0.050 |
Why?
|
Cell Differentiation | 7 | 2021 | 11478 | 0.050 |
Why?
|
K562 Cells | 2 | 2015 | 635 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2583 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 431 | 0.050 |
Why?
|
Suramin | 1 | 2022 | 34 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7729 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4152 | 0.050 |
Why?
|
Probenecid | 1 | 2022 | 76 | 0.050 |
Why?
|
Chloride Channels | 2 | 2001 | 227 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2014 | 1968 | 0.050 |
Why?
|
Amino Acid Sequence | 7 | 2019 | 13809 | 0.050 |
Why?
|
Hypotonic Solutions | 3 | 1998 | 49 | 0.050 |
Why?
|
Platelet Activating Factor | 1 | 2002 | 149 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2008 | 2453 | 0.050 |
Why?
|
Gene Deletion | 3 | 2021 | 2749 | 0.050 |
Why?
|
Calcium Signaling | 2 | 2019 | 721 | 0.050 |
Why?
|
Up-Regulation | 2 | 2008 | 4221 | 0.050 |
Why?
|
Phenotype | 8 | 2019 | 16361 | 0.050 |
Why?
|
Phthalic Acids | 1 | 2006 | 436 | 0.050 |
Why?
|
Bilirubin | 2 | 2012 | 425 | 0.050 |
Why?
|
Cell Survival | 4 | 2019 | 5881 | 0.050 |
Why?
|
Track and Field | 1 | 2000 | 7 | 0.050 |
Why?
|
Benzaldehydes | 1 | 2021 | 58 | 0.050 |
Why?
|
False Positive Reactions | 2 | 2000 | 980 | 0.050 |
Why?
|
Animals, Genetically Modified | 1 | 2006 | 1552 | 0.050 |
Why?
|
Permeability | 2 | 2021 | 738 | 0.050 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2002 | 293 | 0.050 |
Why?
|
Boxing | 1 | 2000 | 15 | 0.050 |
Why?
|
Dinucleotide Repeats | 1 | 2000 | 30 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1213 | 0.050 |
Why?
|
Urea | 1 | 2003 | 450 | 0.050 |
Why?
|
Kidney Concentrating Ability | 1 | 2000 | 41 | 0.050 |
Why?
|
Neoplasms | 2 | 2008 | 21675 | 0.050 |
Why?
|
Oxyhemoglobins | 3 | 2014 | 216 | 0.050 |
Why?
|
Trans-Activators | 2 | 2001 | 2927 | 0.050 |
Why?
|
Hypertension | 7 | 1987 | 8480 | 0.050 |
Why?
|
Tyrosine | 1 | 2005 | 1462 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2022 | 4204 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3769 | 0.050 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1998 | 189 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17439 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15067 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9975 | 0.050 |
Why?
|
Marine Toxins | 1 | 1999 | 24 | 0.050 |
Why?
|
Vitamin E | 1 | 2004 | 868 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2021 | 21733 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2003 | 1105 | 0.040 |
Why?
|
Magnesium Deficiency | 2 | 1997 | 47 | 0.040 |
Why?
|
Middle Aged | 19 | 2020 | 213241 | 0.040 |
Why?
|
DNA, Complementary | 6 | 1999 | 2050 | 0.040 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2001 | 114 | 0.040 |
Why?
|
Clinical Chemistry Tests | 1 | 2020 | 61 | 0.040 |
Why?
|
Point Mutation | 2 | 1995 | 1623 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2077 | 0.040 |
Why?
|
Genotype | 4 | 2023 | 12944 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 2000 | 438 | 0.040 |
Why?
|
Swimming | 1 | 2000 | 205 | 0.040 |
Why?
|
Mitochondria | 1 | 2012 | 3513 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2002 | 498 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2001 | 529 | 0.040 |
Why?
|
Adenosine Triphosphate | 3 | 2022 | 2029 | 0.040 |
Why?
|
Pilot Projects | 3 | 2015 | 8316 | 0.040 |
Why?
|
Splenomegaly | 1 | 2019 | 190 | 0.040 |
Why?
|
Apyrase | 1 | 2022 | 364 | 0.040 |
Why?
|
Methylation | 1 | 2002 | 1104 | 0.040 |
Why?
|
Pediatrics | 2 | 2006 | 3474 | 0.040 |
Why?
|
Fibrinolysis | 1 | 2000 | 322 | 0.040 |
Why?
|
Blood Transfusion | 3 | 2021 | 1301 | 0.040 |
Why?
|
Solubility | 1 | 2001 | 1088 | 0.040 |
Why?
|
Bicycling | 1 | 2000 | 176 | 0.040 |
Why?
|
Oscillometry | 1 | 2019 | 146 | 0.040 |
Why?
|
Threonine | 1 | 1999 | 279 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2013 | 2839 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2001 | 9648 | 0.040 |
Why?
|
Naphthalenes | 1 | 1999 | 194 | 0.040 |
Why?
|
DNA Primers | 3 | 2007 | 2891 | 0.040 |
Why?
|
Viscosity | 1 | 2019 | 328 | 0.040 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 1998 | 57 | 0.040 |
Why?
|
Aged | 9 | 2021 | 163178 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 670 | 0.040 |
Why?
|
gamma-Globins | 1 | 2019 | 95 | 0.040 |
Why?
|
Teaching | 1 | 2006 | 1173 | 0.040 |
Why?
|
Oxazoles | 1 | 1999 | 189 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2007 | 2969 | 0.040 |
Why?
|
Double-Blind Method | 4 | 2011 | 12020 | 0.040 |
Why?
|
Anemia, Megaloblastic | 1 | 1998 | 25 | 0.040 |
Why?
|
Zebrafish | 4 | 2012 | 2995 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2914 | 0.040 |
Why?
|
Ribavirin | 1 | 2000 | 394 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1999 | 250 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2916 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2005 | 4552 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2020 | 77410 | 0.040 |
Why?
|
Anions | 2 | 1988 | 133 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 279 | 0.040 |
Why?
|
Meningococcal Infections | 1 | 1998 | 77 | 0.040 |
Why?
|
Macaca mulatta | 2 | 2015 | 2375 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2001 | 528 | 0.040 |
Why?
|
Protein C | 1 | 1998 | 138 | 0.040 |
Why?
|
Down-Regulation | 3 | 2014 | 3000 | 0.040 |
Why?
|
Genome, Viral | 1 | 2021 | 665 | 0.040 |
Why?
|
Ischemia | 1 | 2006 | 1907 | 0.040 |
Why?
|
Hemoglobin C | 2 | 1989 | 21 | 0.040 |
Why?
|
Thrombelastography | 1 | 2019 | 164 | 0.040 |
Why?
|
Streptokinase | 1 | 1997 | 189 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 1997 | 230 | 0.040 |
Why?
|
Nephelometry and Turbidimetry | 1 | 1997 | 91 | 0.040 |
Why?
|
Cations, Divalent | 2 | 1987 | 166 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 6098 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2000 | 327 | 0.040 |
Why?
|
Elasticity | 1 | 2019 | 657 | 0.040 |
Why?
|
Xenopus | 4 | 2000 | 712 | 0.040 |
Why?
|
Athletic Performance | 1 | 2017 | 95 | 0.040 |
Why?
|
United States | 6 | 2017 | 69859 | 0.040 |
Why?
|
Blood Transfusion, Autologous | 1 | 1997 | 134 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3778 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2002 | 789 | 0.040 |
Why?
|
Drug Therapy, Combination | 4 | 2021 | 6487 | 0.040 |
Why?
|
Sound | 1 | 2018 | 260 | 0.040 |
Why?
|
DNA, Intergenic | 1 | 2017 | 107 | 0.040 |
Why?
|
Genome | 3 | 2000 | 1806 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2007 | 7719 | 0.040 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1997 | 337 | 0.030 |
Why?
|
Cytosol | 1 | 1999 | 901 | 0.030 |
Why?
|
Trace Elements | 1 | 2018 | 197 | 0.030 |
Why?
|
Uremia | 1 | 1997 | 200 | 0.030 |
Why?
|
Oligopeptides | 1 | 2002 | 1188 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2002 | 1200 | 0.030 |
Why?
|
Cations, Monovalent | 2 | 2013 | 25 | 0.030 |
Why?
|
Menstruation | 1 | 2017 | 302 | 0.030 |
Why?
|
Cloning, Molecular | 5 | 2000 | 4320 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2013 | 10940 | 0.030 |
Why?
|
Food, Fortified | 1 | 1997 | 191 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 5983 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2001 | 1434 | 0.030 |
Why?
|
Dithiothreitol | 1 | 1995 | 101 | 0.030 |
Why?
|
Imidazoline Receptors | 1 | 1995 | 13 | 0.030 |
Why?
|
Sodium Channels | 1 | 1998 | 349 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 1998 | 231 | 0.030 |
Why?
|
Serine | 1 | 1999 | 825 | 0.030 |
Why?
|
Family Health | 1 | 2001 | 1280 | 0.030 |
Why?
|
Vitamins | 1 | 2004 | 1622 | 0.030 |
Why?
|
Hemodynamics | 1 | 2006 | 4197 | 0.030 |
Why?
|
Acetonitriles | 1 | 1995 | 53 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-hck | 2 | 2005 | 46 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1423 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1344 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1195 | 0.030 |
Why?
|
Tetrazoles | 1 | 2001 | 834 | 0.030 |
Why?
|
Proteomics | 1 | 2008 | 3639 | 0.030 |
Why?
|
Cell Line | 6 | 2016 | 15993 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 40545 | 0.030 |
Why?
|
Benzofurans | 1 | 1996 | 140 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1998 | 880 | 0.030 |
Why?
|
Volatilization | 1 | 2014 | 82 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2004 | 4561 | 0.030 |
Why?
|
Monomethylhydrazine | 1 | 1994 | 1 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 967 | 0.030 |
Why?
|
Interleukins | 1 | 1999 | 791 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2017 | 1374 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2014 | 115 | 0.030 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.030 |
Why?
|
Blood Platelets | 1 | 2005 | 2509 | 0.030 |
Why?
|
Partial Pressure | 1 | 2014 | 254 | 0.030 |
Why?
|
Portal Vein | 1 | 1997 | 437 | 0.030 |
Why?
|
Centrifugation | 1 | 2014 | 122 | 0.030 |
Why?
|
Neurotoxins | 1 | 1995 | 237 | 0.030 |
Why?
|
Neutrophils | 2 | 2018 | 3718 | 0.030 |
Why?
|
alpha-Globins | 1 | 2014 | 17 | 0.030 |
Why?
|
Freeze Fracturing | 1 | 1994 | 68 | 0.030 |
Why?
|
Polymerase Chain Reaction | 4 | 2001 | 6170 | 0.030 |
Why?
|
Zambia | 1 | 2014 | 261 | 0.030 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1404 | 0.030 |
Why?
|
Oocytes | 3 | 2009 | 1186 | 0.030 |
Why?
|
Regression Analysis | 3 | 2005 | 6457 | 0.030 |
Why?
|
Complement Membrane Attack Complex | 2 | 1991 | 112 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2883 | 0.030 |
Why?
|
Splenectomy | 1 | 2015 | 394 | 0.030 |
Why?
|
Blood Banks | 1 | 2014 | 111 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1738 | 0.030 |
Why?
|
Adult Children | 1 | 2014 | 100 | 0.030 |
Why?
|
Isoenzymes | 1 | 1998 | 1728 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2006 | 3070 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2006 | 3482 | 0.030 |
Why?
|
Peroxiredoxins | 1 | 2013 | 51 | 0.030 |
Why?
|
Piperidines | 1 | 2002 | 1601 | 0.030 |
Why?
|
Feedback | 1 | 1997 | 795 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1998 | 1098 | 0.030 |
Why?
|
RNA | 3 | 1999 | 2748 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 1181 | 0.030 |
Why?
|
Cell Shape | 1 | 2014 | 375 | 0.030 |
Why?
|
Ferrous Compounds | 1 | 1993 | 42 | 0.030 |
Why?
|
Antigens | 1 | 1999 | 1466 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2002 | 2440 | 0.030 |
Why?
|
Catalase | 1 | 2013 | 221 | 0.030 |
Why?
|
Bucladesine | 1 | 2012 | 121 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5867 | 0.030 |
Why?
|
Pain Measurement | 1 | 2003 | 3420 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 1997 | 660 | 0.030 |
Why?
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1989 | 34 | 0.030 |
Why?
|
Methazolamide | 2 | 1989 | 9 | 0.030 |
Why?
|
Ferrochelatase | 1 | 2012 | 46 | 0.030 |
Why?
|
Risk Assessment | 2 | 2018 | 23327 | 0.030 |
Why?
|
Total Quality Management | 1 | 1994 | 274 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2002 | 1900 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2006 | 13028 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1994 | 667 | 0.030 |
Why?
|
Drug Resistance | 2 | 1995 | 1606 | 0.030 |
Why?
|
Genetic Techniques | 1 | 2015 | 435 | 0.030 |
Why?
|
Financial Management | 1 | 1994 | 160 | 0.030 |
Why?
|
Kidney | 4 | 2009 | 7185 | 0.030 |
Why?
|
Isoelectric Point | 1 | 1992 | 79 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1997 | 1503 | 0.030 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2012 | 190 | 0.030 |
Why?
|
Sheep | 3 | 1990 | 1437 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1252 | 0.030 |
Why?
|
History, 19th Century | 1 | 2014 | 720 | 0.030 |
Why?
|
Calorimetry | 1 | 1992 | 126 | 0.030 |
Why?
|
Intestinal Mucosa | 3 | 2000 | 3038 | 0.030 |
Why?
|
Microscopy, Atomic Force | 1 | 2012 | 250 | 0.030 |
Why?
|
Regenerative Medicine | 1 | 2015 | 308 | 0.030 |
Why?
|
Cell Division | 2 | 2000 | 4568 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2012 | 561 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 1995 | 642 | 0.030 |
Why?
|
Hepatitis C, Chronic | 1 | 2000 | 1029 | 0.030 |
Why?
|
Gestational Age | 1 | 2000 | 3488 | 0.020 |
Why?
|
Cytoskeleton | 2 | 2012 | 1185 | 0.020 |
Why?
|
Societies | 1 | 2012 | 104 | 0.020 |
Why?
|
Nitrates | 1 | 1993 | 265 | 0.020 |
Why?
|
Liver | 2 | 2019 | 7479 | 0.020 |
Why?
|
Treatment Failure | 1 | 1997 | 2617 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2012 | 424 | 0.020 |
Why?
|
Freezing | 1 | 1992 | 303 | 0.020 |
Why?
|
Quality Control | 1 | 1994 | 841 | 0.020 |
Why?
|
Models, Molecular | 2 | 2016 | 5445 | 0.020 |
Why?
|
Mesylates | 1 | 2011 | 36 | 0.020 |
Why?
|
Shock, Septic | 1 | 1998 | 775 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4183 | 0.020 |
Why?
|
Ethics Committees | 1 | 2010 | 54 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2000 | 1940 | 0.020 |
Why?
|
Rural Health Services | 1 | 2014 | 380 | 0.020 |
Why?
|
Veins | 1 | 2015 | 770 | 0.020 |
Why?
|
Malaria | 1 | 2021 | 1239 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 1997 | 1263 | 0.020 |
Why?
|
Drug Interactions | 1 | 1995 | 1460 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2008 | 5388 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 1995 | 839 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 13869 | 0.020 |
Why?
|
Methylamines | 1 | 2011 | 122 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2177 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1997 | 2369 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 1970 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 712 | 0.020 |
Why?
|
Complement Activation | 2 | 1989 | 453 | 0.020 |
Why?
|
Scientific Misconduct | 1 | 2010 | 71 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2646 | 0.020 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 169 | 0.020 |
Why?
|
Publication Bias | 1 | 2010 | 162 | 0.020 |
Why?
|
STAT5 Transcription Factor | 2 | 2001 | 259 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 5532 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 1993 | 527 | 0.020 |
Why?
|
Biological Availability | 2 | 2005 | 397 | 0.020 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1989 | 24 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 12066 | 0.020 |
Why?
|
RNA, Complementary | 1 | 2009 | 45 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 1998 | 2764 | 0.020 |
Why?
|
Transfection | 2 | 2013 | 5892 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1995 | 953 | 0.020 |
Why?
|
Fetal Blood | 1 | 2015 | 1318 | 0.020 |
Why?
|
Thromboembolism | 1 | 2015 | 987 | 0.020 |
Why?
|
bcl-X Protein | 2 | 2001 | 411 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10629 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1994 | 1680 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3680 | 0.020 |
Why?
|
Triglycerides | 2 | 1995 | 2453 | 0.020 |
Why?
|
Chloride-Bicarbonate Antiporters | 2 | 1998 | 103 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2009 | 670 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 795 | 0.020 |
Why?
|
Intestines | 1 | 1997 | 1923 | 0.020 |
Why?
|
Colon | 1 | 1996 | 1772 | 0.020 |
Why?
|
Electrocoagulation | 1 | 2008 | 158 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 4009 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1295 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 1997 | 2162 | 0.020 |
Why?
|
Particle Size | 1 | 2012 | 1639 | 0.020 |
Why?
|
Prevalence | 3 | 2017 | 15211 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 3024 | 0.020 |
Why?
|
Transcription Factors | 2 | 2014 | 12209 | 0.020 |
Why?
|
Troponin I | 1 | 2012 | 619 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2012 | 1081 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 79 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2000 | 2984 | 0.020 |
Why?
|
Hepatocytes | 1 | 2014 | 1211 | 0.020 |
Why?
|
Graft Survival | 1 | 1998 | 3734 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1702 | 0.020 |
Why?
|
Gene Expression | 2 | 2016 | 7793 | 0.020 |
Why?
|
Molecular Weight | 1 | 2009 | 2253 | 0.020 |
Why?
|
Apoptosis | 2 | 2001 | 9718 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1342 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2504 | 0.020 |
Why?
|
Mice, Inbred NZB | 1 | 2006 | 56 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1800 | 0.020 |
Why?
|
Drug Combinations | 2 | 2007 | 1958 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 365 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2013 | 3622 | 0.020 |
Why?
|
Folic Acid | 1 | 1993 | 1293 | 0.020 |
Why?
|
Bradykinin | 1 | 1986 | 214 | 0.020 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2006 | 158 | 0.020 |
Why?
|
Glycosylation | 2 | 1999 | 1129 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 443 | 0.020 |
Why?
|
Electrophysiology | 2 | 2004 | 1297 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3504 | 0.020 |
Why?
|
Molsidomine | 1 | 2005 | 21 | 0.020 |
Why?
|
Intracellular Fluid | 2 | 1996 | 203 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2000 | 2327 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1962 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2007 | 892 | 0.020 |
Why?
|
Cell Lineage | 1 | 2014 | 2506 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3339 | 0.020 |
Why?
|
Lod Score | 1 | 2005 | 613 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1988 | 796 | 0.020 |
Why?
|
Markov Chains | 1 | 2008 | 968 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 1998 | 6311 | 0.020 |
Why?
|
Homozygote | 1 | 1989 | 1787 | 0.020 |
Why?
|
Vasopressins | 1 | 1986 | 370 | 0.020 |
Why?
|
Autoanalysis | 1 | 2004 | 72 | 0.020 |
Why?
|
Ergotamines | 1 | 1984 | 4 | 0.020 |
Why?
|
DNA | 2 | 2000 | 7295 | 0.020 |
Why?
|
Spleen | 2 | 2001 | 2359 | 0.020 |
Why?
|
Hypertension, Renal | 2 | 1986 | 177 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1987 | 546 | 0.010 |
Why?
|
Blood Volume | 1 | 2005 | 565 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5854 | 0.010 |
Why?
|
Exons | 2 | 2000 | 2438 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 1411 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 1997 | 39001 | 0.010 |
Why?
|
Parotid Gland | 1 | 2004 | 168 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
Endothelium | 1 | 1986 | 777 | 0.010 |
Why?
|
Animals, Newborn | 2 | 2000 | 2725 | 0.010 |
Why?
|
Acid-Base Equilibrium | 1 | 1984 | 185 | 0.010 |
Why?
|
Prognosis | 2 | 2008 | 29052 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1938 | 0.010 |
Why?
|
Inheritance Patterns | 1 | 2005 | 339 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1678 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4418 | 0.010 |
Why?
|
Scavenger Receptors, Class B | 1 | 2002 | 82 | 0.010 |
Why?
|
Prospective Studies | 2 | 2005 | 53250 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2471 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 959 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 2001 | 107 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1207 | 0.010 |
Why?
|
Rats | 4 | 2001 | 24250 | 0.010 |
Why?
|
Receptors, Lipoprotein | 1 | 2002 | 81 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1994 | 1877 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 2006 | 601 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3847 | 0.010 |
Why?
|
Receptors, Scavenger | 1 | 2002 | 121 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2692 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5611 | 0.010 |
Why?
|
Health Personnel | 1 | 2014 | 3217 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5445 | 0.010 |
Why?
|
E2F4 Transcription Factor | 1 | 2000 | 36 | 0.010 |
Why?
|
Hemorrhage | 1 | 1993 | 3458 | 0.010 |
Why?
|
Phagosomes | 1 | 2002 | 193 | 0.010 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2000 | 40 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1729 | 0.010 |
Why?
|
Staurosporine | 1 | 2001 | 251 | 0.010 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2000 | 31 | 0.010 |
Why?
|
Chromosome Walking | 1 | 2000 | 27 | 0.010 |
Why?
|
Child Health Services | 1 | 2006 | 666 | 0.010 |
Why?
|
Risk Factors | 4 | 2014 | 72252 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.010 |
Why?
|
Saliva | 1 | 2004 | 809 | 0.010 |
Why?
|
Yolk Sac | 1 | 2000 | 75 | 0.010 |
Why?
|
Drug Administration Schedule | 3 | 1994 | 4931 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 1985 | 789 | 0.010 |
Why?
|
Retinal Diseases | 1 | 1986 | 685 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2000 | 448 | 0.010 |
Why?
|
Poly A | 1 | 1999 | 185 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2251 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1984 | 793 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1999 | 427 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2000 | 1085 | 0.010 |
Why?
|
Genes, Immediate-Early | 1 | 1999 | 101 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2000 | 383 | 0.010 |
Why?
|
Friend murine leukemia virus | 1 | 1998 | 65 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 378 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1999 | 829 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2005 | 3701 | 0.010 |
Why?
|
Survival Analysis | 2 | 2005 | 10251 | 0.010 |
Why?
|
Models, Genetic | 2 | 1999 | 3492 | 0.010 |
Why?
|
Cost of Illness | 1 | 2008 | 1859 | 0.010 |
Why?
|
5' Untranslated Regions | 1 | 1999 | 249 | 0.010 |
Why?
|
Enterocytes | 1 | 2000 | 225 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4749 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1869 | 0.010 |
Why?
|
Diet | 1 | 1996 | 7930 | 0.010 |
Why?
|
Complement C3 | 1 | 2000 | 461 | 0.010 |
Why?
|
Renal Artery | 1 | 1980 | 399 | 0.010 |
Why?
|
Tetraethylammonium Compounds | 1 | 1997 | 32 | 0.010 |
Why?
|
Tetraethylammonium | 1 | 1997 | 58 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1999 | 1581 | 0.010 |
Why?
|
Craniofacial Abnormalities | 1 | 2000 | 315 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3281 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15518 | 0.010 |
Why?
|
Cross Reactions | 1 | 1999 | 841 | 0.010 |
Why?
|
Prothrombin | 1 | 1998 | 185 | 0.010 |
Why?
|
Superior Cervical Ganglion | 1 | 1997 | 33 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 1999 | 513 | 0.010 |
Why?
|
Introns | 1 | 2000 | 991 | 0.010 |
Why?
|
Survival | 1 | 1998 | 163 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1999 | 1095 | 0.010 |
Why?
|
Toxins, Biological | 1 | 1997 | 66 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2000 | 389 | 0.010 |
Why?
|
Binding Sites | 2 | 1996 | 6111 | 0.010 |
Why?
|
4-Aminopyridine | 1 | 1997 | 81 | 0.010 |
Why?
|
PC12 Cells | 1 | 1997 | 331 | 0.010 |
Why?
|
Bicarbonates | 1 | 1998 | 312 | 0.010 |
Why?
|
Nutrition Disorders | 1 | 1997 | 211 | 0.010 |
Why?
|
Ferrets | 1 | 1997 | 194 | 0.010 |
Why?
|
Glyburide | 1 | 1997 | 113 | 0.010 |
Why?
|
Cytoplasm | 1 | 2001 | 1536 | 0.010 |
Why?
|
Cholesterol | 2 | 2002 | 2922 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2000 | 811 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2000 | 566 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 2000 | 895 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1997 | 240 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1998 | 437 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9582 | 0.010 |
Why?
|
Interferons | 1 | 2000 | 706 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2002 | 1436 | 0.010 |
Why?
|
Fetal Diseases | 1 | 2001 | 903 | 0.010 |
Why?
|
Genes, Recessive | 1 | 1998 | 641 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1998 | 799 | 0.010 |
Why?
|
Cattle | 2 | 1995 | 3917 | 0.010 |
Why?
|
Endotoxins | 1 | 1998 | 527 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2000 | 717 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2002 | 1151 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1997 | 419 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 1997 | 399 | 0.010 |
Why?
|
Miconazole | 1 | 1994 | 7 | 0.010 |
Why?
|
Serum Albumin | 1 | 1997 | 675 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1996 | 960 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 1995 | 402 | 0.010 |
Why?
|
Actins | 1 | 2002 | 2121 | 0.010 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1997 | 548 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2503 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2001 | 1403 | 0.010 |
Why?
|
Autophagy | 1 | 2002 | 1296 | 0.010 |
Why?
|
3T3 Cells | 1 | 1995 | 1102 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2002 | 1885 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1781 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1997 | 1892 | 0.010 |
Why?
|
Molecular Structure | 1 | 1997 | 1894 | 0.010 |
Why?
|
Cell Polarity | 1 | 1996 | 645 | 0.010 |
Why?
|
Sex Factors | 2 | 1986 | 10394 | 0.010 |
Why?
|
Heart Diseases | 1 | 1986 | 2789 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1996 | 1472 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2419 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2256 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2123 | 0.010 |
Why?
|
Creatinine | 1 | 1997 | 1918 | 0.010 |
Why?
|
Cell Cycle | 1 | 2000 | 2963 | 0.010 |
Why?
|
Epithelium | 1 | 1996 | 1679 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4386 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1995 | 1245 | 0.010 |
Why?
|
Drug Synergism | 1 | 1996 | 1794 | 0.010 |
Why?
|
Genetic Markers | 1 | 1998 | 2634 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1995 | 1202 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12243 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6356 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1995 | 2085 | 0.010 |
Why?
|
Placenta | 1 | 2000 | 1699 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2861 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9440 | 0.010 |
Why?
|
Mice, SCID | 1 | 1995 | 2718 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 57744 | 0.010 |
Why?
|
Electrochemistry | 1 | 1989 | 145 | 0.010 |
Why?
|
Colloids | 1 | 1989 | 136 | 0.010 |
Why?
|
Pregnancy | 2 | 2004 | 29140 | 0.010 |
Why?
|
Osmotic Pressure | 1 | 1989 | 151 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1989 | 1386 | 0.000 |
Why?
|
Neoplastic Stem Cells | 1 | 1995 | 1376 | 0.000 |
Why?
|
Sodium Chloride | 1 | 1989 | 625 | 0.000 |
Why?
|
Lactates | 1 | 1987 | 431 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3758 | 0.000 |
Why?
|
Membrane Lipids | 1 | 1987 | 251 | 0.000 |
Why?
|
Umbilical Veins | 1 | 1986 | 433 | 0.000 |
Why?
|
Kidney Tubules | 1 | 1987 | 488 | 0.000 |
Why?
|
Dogs | 1 | 1990 | 3911 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9848 | 0.000 |
Why?
|
Obesity | 1 | 1987 | 12744 | 0.000 |
Why?
|
Radioisotopes | 1 | 1986 | 500 | 0.000 |
Why?
|
Vasoconstriction | 1 | 1987 | 597 | 0.000 |
Why?
|
Ergotamine | 1 | 1984 | 7 | 0.000 |
Why?
|
Escherichia coli | 1 | 1997 | 4216 | 0.000 |
Why?
|
Aging | 1 | 1983 | 8655 | 0.000 |
Why?
|
Celiac Artery | 1 | 1984 | 69 | 0.000 |
Why?
|
Thrombosis | 1 | 1998 | 2968 | 0.000 |
Why?
|
Mesenteric Arteries | 1 | 1984 | 183 | 0.000 |
Why?
|
Comorbidity | 1 | 1997 | 10380 | 0.000 |
Why?
|
Brachial Artery | 1 | 1984 | 369 | 0.000 |
Why?
|
Lactic Acid | 1 | 1987 | 1131 | 0.000 |
Why?
|
Phospholipids | 1 | 1985 | 784 | 0.000 |
Why?
|
Software | 1 | 1995 | 4440 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1986 | 1084 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1997 | 5752 | 0.000 |
Why?
|
Melanoma | 1 | 1995 | 5508 | 0.000 |
Why?
|
Lipids | 1 | 1987 | 3307 | 0.000 |
Why?
|
Blood Pressure | 1 | 1987 | 8551 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1995 | 13112 | 0.000 |
Why?
|
Age Factors | 1 | 1986 | 18355 | 0.000 |
Why?
|
Radiography | 1 | 1980 | 7010 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1982 | 15142 | 0.000 |
Why?
|